Influenza and Pneumococcal Vaccination in Non-Infected Cardiometabolic Patients from the Americas during the COVID-19 Pandemic. A Sub-Analysis of the CorCOVID-LATAM Study
Open Access
- 4 February 2021
- Vol. 9 (2), 123
- https://doi.org/10.3390/vaccines9020123
Abstract
Background: Influenza vaccination (IV) and Pneumococcus vaccination (PV) are recommended for patients with cardiometabolic diseases. This study aimed to evaluate the immunization rate of ambulatory cardiometabolic patients during the COVID-19 pandemic in the Americas. Methods: Electronic surveys were collected from 13 Spanish speaking countries between 15 June and 15 July 2020. Results: 4216 patients were analyzed. Mean age 60 (±15) years and 49% females. Global IV rate was 46.5% and PV 24.6%. Vaccinated patients were older (IV = 63 vs. 58 years; PV = 68 vs. 59, p < 0.01) but without gender difference. Vaccination rates were greater in higher-risk groups (65+, diabetics, heart failure), but not in coronary artery disease patients. In the Southern cone, the rate of IV and PV was approximately double that in the tropical regions of the Americas. In a multivariate model, geographic zone (IV = OR 2.02, PV = OR 2.42, p < 0.001), age (IV = OR 1.023, PV = OR 1.035, p < 0.001), and incomes (IV = OR 1.28, PV = OR 1.58, p < 0.001) were predictors for vaccination. Conclusions: During the COVID-19 pandemic, ambulatory patients with cardiometabolic diseases from the Americas with no evidence of COVID-19 infection had lower-than-expected rates of IV and PV. Geographic, social, and cultural differences were found, and they should be explored in depth.This publication has 61 references indexed in Scilit:
- Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-upBMC Public Health, 2012
- Influenza vaccination reduces cardiovascular events in patients with acute coronary syndromeEuropean Heart Journal, 2011
- Epidemiology and risk profile of heart failureNature Reviews Cardiology, 2010
- Prevention of Acute Myocardial Infarction and Stroke among Elderly Persons by Dual Pneumococcal and Influenza Vaccination: A Prospective Cohort StudyClinical Infectious Diseases, 2010
- Pneumococcal vaccination and risk of myocardial infarctionCMAJ : Canadian Medical Association Journal, 2008
- Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice databaseEuropean Heart Journal, 2007
- Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34 892 subjectsEuropean Heart Journal, 2007
- Influenza Vaccination in the ElderlyDrugs & Aging, 2005
- Influenza Vaccine Pilot Study in Acute Coronary Syndromes and Planned Percutaneous Coronary InterventionsCirculation, 2002
- Importance of patients’ perceptions and general practitioners’ recommendations in understanding missed opportunities for immunisations in Swiss adultsVaccine, 2001